VeinOPlus DVT

All Patients including Post-Surgical and ICU are at Risk for DVT due to Calf Muscle Pump Dysfunction.

It’s time to rethink how best to treat calf muscle pump dysfunction and prevent venous stasis in all immobilized patients.

Facts:

1) Calf muscle pump dysfunction develops during hospitalization. Bed stay leads to a reduction in heart rate and a 47% decrease in venous outflow.

2) 50% of clots originate in the valve cusps of the soleal veins due to stasis.

3) More than 75% of DVTs develop between day one and the ninth day.

4) DVT develops on average, 17 days following TKR and 27 days after THR.

5) Risk of DVT extends until patients are fully ambulatory, making prophylaxis critical.

6) Only 20% of surgical patients receive SCD prophylaxis after discharged.

How blood clots form?

20% Factor with SCDs

SCDs fail to treat calf muscle pump dysfunction.

Preventing DVT… One Impulse at a Time with VeinOPlus DVT

VeinOPlus DVT is an ultra-portable electro-muscle stimulator (EMS) device, weighing 24 grams and powered by a 9 volt battery. The device treats and prevents calf muscle pump dysfunction, promotes patient compliance, prevents venous stasis, and subsequently DVT.

VeinOPlus DVT is programmed to run for 3 hours before auto shut-off. The device operates on a recurring five minute cyclic signal pattern.

During the first 4 minutes, the device delivers 60 impulses each minute. This segment of the cycle is designed to increase venous outflow volume and prevents stasis.

VeinOPlus DVT increases venous outflow volume 1.4 to 3.3 times more than SCDs.

During the 5th minute, the impulse signal pattern changes by design to increase venous velocity. The impulse signal drops from 60 impulses per minute to 27 impulses with intervals of 1 to 8 seconds. This signal pattern maximizes increased venous outflow velocity and prevents venous pooling behind the valve cusps.

VeinOPlus DVT increases venous outflow velocity 1.4 times greater than SCDs.

100% Factor with VeinOPlus DVT

During a 3-hour therapy session, VeinOPlus® DVT generates 9,612 calf muscle contractions, while SCDs deliver approximately 180 compression cycles.

Watch how VeinOPlus DVT prevents DVT


The first 9 seconds and the last 22 seconds of the video depicts the effect of how 60 impulses per minute (during the first 4 minutes) assures venous volume outflow and prevents venous stasis.

From 9 – 35 seconds, the video depicts how the programming of 27 impulses during the fifth minute significantly increases venous velocity outflow and clears pooling of venous blood behind the valve cusps of the soleal veins. This is crucial since a majority of clots form behind the valve cusps. VeinOPlus DVT increases venous outflow velocity 1.4 times greater than SCDs.

Summary of the VeinOPlus DVT device:
Single-use and ultra-portability provides access to all patients at risk of DVT.
Significantly reduces hospital costs and the incidence of re-admissions.
High patient compliance due to comfortable therapy and ease of use.
Extended hours of use does not cause ischemia or limb pain.
Improved arterial inflow 4 times accelerates wound healing.
Rehabilitation and length of stay is reduced.
Increased venous outflow volume/velocity reduces peripheral edema and pain.
Prevention of venous stasis and DVT is achieved.

Calculate the # of Preventable VTE’s/Savings for your Hospital

Calculate the # of Preventable VTE’s/Savings for your Hospital

Calculate the # of Preventable VTE’s/Savings for your Hospital

It’s Time to Prescribe a Real Solution in Preventing DVT!